ID
45803
Description
Principal Investigator: David Solit, MD, Memorial Sloan Kettering Cancer Center, New York, NY, USA MeSH: Carcinoma, Signet Ring Cell,Urinary Bladder Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001064 In this study, six plasmacytoid bladder cancers were analyzed by whole exome sequencing. The results show loss of the CDH1 gene in every sample and correlate with E-cadherin loss of expression by immunohistochemistry. A separate validation cohort of plasmacytoid samples showed loss of E-cadherin expression by CDH1 mutation or promoter hypermethylation.
Lien
Mots-clés
Versions (1)
- 2023-06-23 2023-06-23 - Chiara Middel
Détendeur de droits
David Solit, MD, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Téléchargé le
23 juni 2023
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
dbGaP phs001064 Whole Exome Sequencing of Signet Ring/Plasmacytoid Variant Bladder Cancer
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent file includes subject IDs and consent information.
- This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample use.
- This subject phenotype table contains subject IDs, age onset, and sex.
- This sample attributes table contains sample IDs, body site, analyte type, tumor status, histological type, primary tumor, metastasis, or transformed cell line, and primary tumor location.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent file includes subject IDs and consent information.
- This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample use.
- This subject phenotype table contains subject IDs, age onset, and sex.
- This sample attributes table contains sample IDs, body site, analyte type, tumor status, histological type, primary tumor, metastasis, or transformed cell line, and primary tumor location.
C0680251 (UMLS CUI [1,2])
C3846158 (UMLS CUI [1,2])
C0205462 (UMLS CUI [1,3])
C0205419 (UMLS CUI [1,4])